Builders FirstSource, Inc. (BLDR)
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Investigation
07/29/2021
Initial Lawsuit
07/29/2021
Lawsuit Progression
10/14/2021
Did AdaptHealth mislead investors in connection with its going public transaction and past organic growth?
This post is open for investors to gather facts, and findings and track their exposure to related lawsuits. We invite investors and shareholders to contribute to this investigation for their own benefit, add events to the factual timeline below and vote on events’ pertinence.
A lawsuit was subsequently filed. We will update this post as it unfolds.
07/19/2021
Jehoshaphat Research publishes a short thesis report alleging that AdaptHealth was a “roll-up” with “obscure” organic growth accounting: “[w]hile management claims (and consensus estimates reflect) an organic growth trajectory of 8-10%, AHCO is in fact experiencing double-digit organic decline. It is also, in our opinion, taking steps to obscure that decline which are expressly forbidden by the SEC.”
“In our research, we spoke with former AHCO executives. One said the M&A process was a “barn fire,” and the overall business is a “house of cards.” Another described an unsustainably aggressive push to pile up assets using excessive leverage. One said that management had “no f**g clue” what organic growth was.”
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$23.96 | $25.47 | $-1.51 | -5.93% |
An AdaptHealth shareholder filed a federal securities class action on behalf of a class consisting of all persons and entities (other than defendants) that purchased or otherwise acquired AdaptHealth securities between November 11, 2019 and July 16, 2021, both dates inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(i) AdaptHealth had misrepresented its organic growth trajectory by retroactively inflating past organic growth numbers without disclosing the changes, in violation of SEC regulations;
(ii) accordingly, the Company had materially overstated its financial prospects;
(iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
10/14/2021
The court issued an order appointing the lead plaintiff and lead counsel.
11/22/2021
This is a federal securities class action on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired AdaptHealth securities between November 8, 2019 and July 16, 2021, both dates inclusive.
Operative complaint
01/20/2022
A motion to dismiss was filed with the court.
06/09/2022
Court Denied the motion to dismiss.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.